Ewa A Ziółkowska International Congress on Neuronal Ceroid Lipofuscinoses 2025

Abstracts this author is presenting:

• Analysis of brain histopathology following pregnenolone treatment in CLN2 disease mice — Poster Session 2
• Assessment of motor and neuropathological parameters following N-Acetyl-Leucine administration in CLN1 mice — Poster Session 3
• Assessing the contribution of the gut microbiome to CLN2 disease: effects of VNAM treatment upon central and enteric nervous system disease — Poster Session 1
• Systemic AAV9 gene therapy mitigates neuromuscular junction degeneration and muscle atrophy in CLN1 disease — Session 3a - Preclinical research
• Investigating the pathophysiological basis of dysphagia in CLN1, CLN2, and CLN3 mouse models and the therapeutic effects of gene therapy — Session 3b continued - Preclinical research